European Journal of Cardiovascular Medicine

Introduction: Left Ventricle being the primary pump of the heart. Left Ventricular Hypertrophy (LVH) has a significant role as a risk and prognostic factor in Cardiovascular and Hypertensive incidences. LVH is a marker of Target organ damage in Hypertension and helps stratifying cardiovascular risk. Electrocardiography and Echocardiography are two of the most important and primary investigations in quickly assessing Left Ventricular Hypertrophy. Although ECG being less sensitive for LVH it is still routinely used. Aim: to determine prevalence of Left Ventricular Hypertrophy  in Primary and Secondary Hypertensive Patients. Method: This was a prospective observational study carried out in the Department of General Medicine, Pacific Medical College and Hospital, Bhilon Ka Bedla, Udaipur, Rajasthan from August 2021 till August 2022. Result: The prevalence of LVH was found to be 54%. Conclusion: The study concluded that LVH development was in 54% of the total patients. The prevalence of LVH was very high and adequate blood pressure control along with regular medication is needed to avoid cardiac complications.